Related Experiment Video
Updated: Nov 8, 2025

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
7SK Acts as an Anti-tumor Factor in Tongue Squamous Cell Carcinoma
Bowen Zhang1,2, Sainan Min3, Qi Guo1,2
1Department of Geriatrics, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Abstract:
Increasing evidence has shown the mechanistic insights about non-coding RNA 7SK in controlling the transcription. However, the biological function and mechanism of 7SK in cancer are largely unclear. Here, we show that 7SK is down-regulated in human tongue squamous carcinoma (TSCC) and acts as a TSCC suppressor through multiple cell-based assays including a migration assay and a xenograft mouse model. The expression level of 7SK was negatively correlated with the size of tumors in the 73 in-house collected TSCC patients. Through combined analysis of 7SK knockdown of RNA-Seq and available published 7SK ChIRP-seq data, we identified 27 of 7SK-regulated genes that were involved in tumor regulation and whose upstream regulatory regions were bound by 7SK. Motif analysis showed that the regulatory sequences of these genes were enriched for transcription factors FOXJ3 and THRA, suggesting a potential involvement of FOXJ3 and THRA in 7SK-regulated genes. Interestingly, the augmented level of FOXJ3 in TSCC patients and previous reports on THRA in other cancers have suggested that these two factors may promote TSCC progression. In support of this idea, we found that 21 out of 27 aforementioned 7SK-associated genes were regulated by FOXJ3 and THRA, and 12 of them were oppositely regulated by 7SK and FOXJ3/THRA. We also found that FOXJ3 and THRA dramatically promoted migration in SCC15 cells. Collectively, we identified 7SK as an antitumor factor and suggested a potential involvement of FOXJ3 and THRA in 7SK-mediated TSCC progression.
Insights
Non-coding RNA 7SK acts as a tumor suppressor in tongue squamous cell carcinoma (TSCC). Its down-regulation correlates with tumor size, and it potentially counteracts the pro-tumorigenic roles of FOXJ3 and THRA.
Area of Science:
- Molecular Biology
- Oncology
- Non-coding RNA Research
Background:
- Non-coding RNA 7SK's role in transcription is known, but its function in cancer remains unclear.
- Understanding 7SK's mechanisms in cancer is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the biological function and mechanism of 7SK in tongue squamous cell carcinoma (TSCC).
- To identify genes regulated by 7SK and potential interacting transcription factors in TSCC.
Main Methods:
- Analysis of 7SK expression in TSCC patient samples.
- Cell-based assays, including migration assays and xenograft mouse models.
- RNA-sequencing (RNA-Seq) after 7SK knockdown combined with publicly available ChIRP-seq data.
- Motif analysis to identify transcription factor binding sites.
Main Results:
- 7SK is down-regulated in TSCC and functions as a tumor suppressor.
- 7SK expression negatively correlates with tumor size in TSCC patients.
- Identified 27 7SK-regulated genes involved in tumor regulation, enriched for transcription factors FOXJ3 and THRA.
- FOXJ3 and THRA promote TSCC cell migration and oppositely regulate 12 genes compared to 7SK.
Conclusions:
- 7SK acts as an antitumor factor in tongue squamous cell carcinoma.
- FOXJ3 and THRA may play a role in promoting TSCC progression, potentially through mechanisms counteracted by 7SK.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

